GeneDx Holdings Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
GeneDx Holdings Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
  • GeneDx Holdings Corp. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.11M, a 2778% increase year-over-year.
  • GeneDx Holdings Corp. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.18M, a 17.5% increase year-over-year.
  • GeneDx Holdings Corp. annual Share-based Payment Arrangement, Expense for 2023 was -$326K, a 101% decline from 2022.
  • GeneDx Holdings Corp. annual Share-based Payment Arrangement, Expense for 2022 was $42M, a 80.9% decline from 2021.
  • GeneDx Holdings Corp. annual Share-based Payment Arrangement, Expense for 2021 was $219M, a 82.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.18M $3.11M +$3M +2778% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$825K -$451K -$499K -1040% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 -$326K -$913K -$1.34M -316% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.01M $431K -$842K -66.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.85M $108K -$22.6M -99.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $24.5M $48K -$17.5M -99.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $42M $422K -$36.5M -98.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $78.5M $1.27M -$16.7M -92.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $95.3M $22.7M +$23.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $72M $17.6M -$147M -89.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $219M $37M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $18M -$11.4M -38.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$519K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $165M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $29.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.